UnitedHealth CFO granted 111.76-share stock award

DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported receiving a grant of 111.76 shares of common stock on June 23, 2026. The award reflects dividend equivalents paid on his outstanding restricted stock units and carries a grant price of $0.00 per share.

The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this compensation-related award, DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock.

Insider Trade Summary

Grant/Award: 111.76 shares

Grant/Award 1 txn

Insider DeVeydt Wayne S

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	111.76	$0.00	$0.00

Holdings After Transaction: Common Stock — 19,778.69 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Key Figures

Shares granted: 111.76 shares Grant price: $0.00/share Post-transaction holdings: 19,778.69 shares +2 more

5 metrics

Shares granted 111.76 shares Dividend equivalents on restricted stock units granted June 23, 2026

Grant price $0.00/share Compensation-related stock award, not an open-market purchase

Post-transaction holdings 19,778.69 shares Direct ownership by Wayne S. DeVeydt after the grant

Transaction code A Classified as grant, award, or other acquisition

Transaction direction Acquire Non-derivative acquisition of common stock as a grant

Key Terms

dividend equivalents, restricted stock units, Form 4

3 terms

dividend equivalents financial

"Represents dividend equivalents paid on outstanding restricted stock units."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

restricted stock units financial

"The dividend equivalents are subject to the same terms as the underlying restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"The Form 4 lists transaction code “A,” described as a grant, award, or other acquisition"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did UnitedHealth Group (UNH) report for Wayne S. DeVeydt?

UnitedHealth Group reported that CFO Wayne S. DeVeydt received 111.76 shares of common stock as a grant. These shares represent dividend equivalents on his outstanding restricted stock units and were awarded at a grant price of $0.00 per share as compensation.

What are the terms of the dividend equivalents reported for UNH’s CFO?

The dividend equivalents granted to UNH’s CFO are subject to the same vesting conditions as the underlying restricted stock units. If those restricted stock units fail to vest, the associated dividend equivalent shares will be forfeited and will not be retained by the reporting person.

How many UnitedHealth (UNH) shares does Wayne S. DeVeydt hold after this Form 4?

After this reported grant, Wayne S. DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock. This figure reflects his direct ownership position immediately following the 111.76-share dividend equivalent award disclosed in the Form 4 filing.

Was the UNH insider transaction an open-market purchase or a compensation grant?

The UNH insider transaction was a compensation-related grant, not an open-market purchase. The Form 4 lists transaction code “A,” described as a grant, award, or other acquisition, with a price of $0.00 per share tied to dividend equivalents on restricted stock units.

On what date did the UnitedHealth (UNH) CFO’s stock award occur?

The stock award to UnitedHealth’s CFO occurred on June 23, 2026. On that date, Wayne S. DeVeydt received 111.76 shares of common stock as dividend equivalents on outstanding restricted stock units, subject to the same vesting conditions as those units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 05:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeVeydt Wayne S

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		111.76(1)	A	$0	19,778.69	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Wayne S. DeVeydt	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)